Invasive fungal infections in hematologic diseases: evidence, challenges, and clinical practice. [PDF]
Blood ResCho SY, Lee CE, Nho D, Lee DG.
europepmc +1 more source
The Four Critical Priority Fungi According to the World Health Organization and the Hope for New Therapies: A Focus on Cell Wall Antifungal Targets. [PDF]
J Fungi (Basel)Marena GD +6 more
europepmc +1 more source
Fosmanogepix: The Novel Anti-Fungal Agent's Comprehensive Review of in Vitro, in Vivo, and Current Insights From Advancing Clinical Trials. [PDF]
CureusAlmajid A +13 more
europepmc +1 more source
Invasive aspergillosis in lung and heart transplant recipients. [PDF]
JHLT OpenMorrissey CO.
europepmc +1 more source
Disseminated Scedosporium infection in the early post-kidney transplant period. [PDF]
Transpl Infect DisRao M, Casias M, Abidi MZ, Abidi MZ.
europepmc +1 more source
Special Issue: Antifungal Agents Recently Approved or under Development. [PDF]
J Fungi (Basel), 2021 Espinel-Ingroff A, Dannaoui E.
europepmc +1 more source
Comprehensive Overview of Candida auris: An Emerging Multidrug-Resistant Fungal Pathogen. [PDF]
J Microbiol BiotechnolKim JS, Cha H, Bahn YS.
europepmc +1 more source
The anti-Aspergillus drug pipeline: Is the glass half full or empty?
Medical Mycology, 2017 N. Osherov, D. Kontoyiannis
semanticscholar +1 more source
Emerging antifungal resistance in Candida parapsilosis: the end of the innocence. [PDF]
NPJ Antimicrob ResistGuinea J +4 more
europepmc +1 more source
A Mini-Review of In Vitro Data for Candida Species, Including C. auris, Isolated during Clinical Trials of Three New Antifungals: Fosmanogepix, Ibrexafungerp, and Rezafungin. [PDF]
J Fungi (Basel)Espinel-Ingroff A, Wiederhold NP.
europepmc +1 more source